# "The MaP Study": Mapping the Patient Journey in MMA and PA

> **NCT03484767** · — · COMPLETED · sponsor: **ModernaTX, Inc.** · enrollment: 97 (actual)

## Conditions studied

- Methylmalonic Acidemia
- Propionic Acidemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03484767
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-20
- **Primary completion:** 2021-05-29
- **Final completion:** 2021-05-29
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03484767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03484767, ""The MaP Study": Mapping the Patient Journey in MMA and PA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03484767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*